Skip to content
healthcare.dev

BOTOX

NDC 0023-1145, onabotulinumtoxinA, injection, powder, lyophilized, for solution, from Allergan, Inc..

Product NDC
0023-1145
Status
Listed
Labeler
Allergan, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRADERMAL, INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103000
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0023-1145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOTULINUM TOXIN TYPE A100 [USP'U]/1

Pharmacologic classes

Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Neuromuscular Blockade [PE]; Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
0023-1145-01000231145011 VIAL in 1 CARTON (0023-1145-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
0023-1145-02000231145021 VIAL in 1 CARTON (0023-1145-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/33d066a9-34ff-4a1a-b38b-d10983df3300
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0023-1145

Use it

Look up 0023-1145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0023-1145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0023-1145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.